Bradley Hauser - 03 Sep 2026 Form 4 Insider Report for Autonomix Medical, Inc. (AMIX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Sep 2026, 16:19:24 UTC
Prior SEC filing
13 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Trent Smith, Attorney-in-Fact for Brad Hauser

Key filing fact

Bradley Hauser filed Form 4 for Autonomix Medical, Inc. (AMIX) on 08 Sep 2026.

Key facts

  • This page summarizes Bradley Hauser's Form 4 filing for Autonomix Medical, Inc. (AMIX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Sep 2026, 16:19.

Change

  • Previous filing in this sequence was filed on 13 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001662139 Primary reporting owner

Hauser Bradley

Relationship
CEO and President
Address
C/O AUTONOMIX MEDICAL, INC., 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Signature
/s/ Trent Smith, Attorney-in-Fact for Brad Hauser
Signature date
08 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMIX transaction

Common Stock

Award

Transaction value
Shares
+27,000
Change %
Price
Shares after
27,000
Date
03 Sep 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .